Decision making for non-invasive neuromodulation prescription in the treatment of neuropathic pain: a roadmap proposal

Summarise with VIRAT
Authors: Abrahão Fontes Baptista, Juliana Barcellos de Souza, Fuad Ahmad Hazime, Rodrigo Pegado, Wolnei Caumo, Kátia Nunes Sá, Ana Mércia Fernandes, Daniel Ciampi De Andrade, Lívia Shirahige, Tiago da Silva Lopes, Katia Karina Monte-Silva, Rafael Jardim Duarte Moreira
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background: Neuropathic pain (NeP) is a complex condition affecting 10–15% of the population, requiring treatment approaches that go beyond pain intensity reduction. Non-invasive brain stimulation (NIBS), including repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS), has emerged as a promising therapeutic strategy. However, clinical decision-making regarding optimal protocols remains challenging. Objective: To develop and externally validate a clinical decision-support roadmap to guide the prescription of NIBS for neuropathic pain. Methods: A structured evidence synthesis was conducted using the PICOS framework, prioritizing systematic reviews with meta-analyses published from 2015 onwards. Data on clinical outcomes, stimulation parameters, and effect sizes were extracted. The most effective protocols were identified through corresponding randomized controlled trials, whose methodological quality was assessed using the PEDro scale. Based on this evidence, a decision-making flowchart was constructed and subsequently evaluated by an independent panel of clinical experts for external validation.Results: Seven meta-analyses and eight randomized clinical trials were included. High-frequency rTMS and anodal tDCS demonstrated significant short-term reductions in pain intensity across multiple neuropathic pain etiologies, with no serious adverse events reported. The resulting roadmap prioritizes rTMS over the primary motor cortex as a first-line approach in most cases, while incorporating alternative strategies for specific conditions. Expert validation supported the clinical logic, clarity, and applicability of the proposed framework. Conclusions: This study presents an evidence-based clinical decision-support roadmap for NIBS prescription in neuropathic pain. Although individual components are supported by high-quality evidence, further studies are required to formally validate the predictive performance and clinical impact of the overall decision model.

Fields of Study & Subjects

Transcranial Magnetic Stimulation Studies Pain Management and Treatment Pain Mechanisms and Treatments

Publication details

Journal / source
OSF Preprints (OSF Preprints)
Publication date
20 March 2026
Language
EN
Document type
Preprint